Co-former selection for co-amorphous drug-amino acid formulationsINTERNATIONAL JOURNAL OF PHARMACEUTICSIF5.22019-02-0189PREAI
Process Optimization and Upscaling of Spray-Dried Drug-Amino acid Co-Amorphous FormulationsPHARMACEUTICSIF5.52019-01-0919OAAI
The use of molecular descriptors in the development of co-amorphous formulations在共无定形制剂的开发中使用分子描述符EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESIF4.72018-07-0130PREAI
Performance comparison between crystalline and co-amorphous salts of indomethacin-lysineINTERNATIONAL JOURNAL OF PHARMACEUTICSIF5.22017-11-0161PREAI
Influence of drug load and physical form of cinnarizine in new SNEDDS dosing regimens: in vivo and in vitro evaluationsAAPS JOURNALIF3.72017-01-0931PREAI
Development of a screening method for co-amorphous formulations of drugs and amino acidsEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESIF4.72016-12-0186PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向